199 related articles for article (PubMed ID: 32704070)
1. Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis.
Parra-Medina R; López-Kleine L; Ramírez-Clavijo S; Payán-Gómez C
Sci Rep; 2020 Jul; 10(1):12345. PubMed ID: 32704070
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.
Srivastava A; Goldberger H; Dimtchev A; Ramalinga M; Chijioke J; Marian C; Oermann EK; Uhm S; Kim JS; Chen LN; Li X; Berry DL; Kallakury BV; Chauhan SC; Collins SP; Suy S; Kumar D
PLoS One; 2013; 8(10):e76994. PubMed ID: 24167554
[TBL] [Abstract][Full Text] [Related]
3. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
Foj L; Filella X
Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
5. Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer.
Chen Y; Chen Z; Mo J; Pang M; Chen Z; Feng F; Xie P; Yang B
Technol Cancer Res Treat; 2021; 20():1533033821990064. PubMed ID: 33596783
[TBL] [Abstract][Full Text] [Related]
6. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
[TBL] [Abstract][Full Text] [Related]
7. Prediction of potential prognostic biomarkers in metastatic prostate cancer based on a circular RNA-mediated competing endogenous RNA regulatory network.
Luo L; Zhang LL; Tao W; Xia TL; Li LY
PLoS One; 2021; 16(12):e0260983. PubMed ID: 34860853
[TBL] [Abstract][Full Text] [Related]
8. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
[TBL] [Abstract][Full Text] [Related]
9. Circulatory miR-628-5p is downregulated in prostate cancer patients.
Srivastava A; Goldberger H; Dimtchev A; Marian C; Soldin O; Li X; Collins SP; Suy S; Kumar D
Tumour Biol; 2014 May; 35(5):4867-73. PubMed ID: 24477576
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
11. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as prognostic markers in prostate cancer.
Suer I; Guzel E; Karatas OF; Creighton CJ; Ittmann M; Ozen M
Prostate; 2019 Feb; 79(3):265-271. PubMed ID: 30345533
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel biomarkers correlated with prostate cancer progression by an integrated bioinformatic analysis.
Ma Z; Wang J; Ding L; Chen Y
Medicine (Baltimore); 2020 Jul; 99(28):e21158. PubMed ID: 32664150
[TBL] [Abstract][Full Text] [Related]
14. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
15. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
16. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
[TBL] [Abstract][Full Text] [Related]
19. Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer.
Rubicz R; Zhao S; Wright JL; Coleman I; Grasso C; Geybels MS; Leonardson A; Kolb S; April C; Bibikova M; Troyer D; Lance R; Lin DW; Ostrander EA; Nelson PS; Fan JB; Feng Z; Stanford JL
Mol Oncol; 2017 Feb; 11(2):140-150. PubMed ID: 28145099
[TBL] [Abstract][Full Text] [Related]
20. Gene networks and microRNAs implicated in aggressive prostate cancer.
Wang L; Tang H; Thayanithy V; Subramanian S; Oberg AL; Cunningham JM; Cerhan JR; Steer CJ; Thibodeau SN
Cancer Res; 2009 Dec; 69(24):9490-7. PubMed ID: 19996289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
